Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $290
تينيت للرعاية الصحية
Tenet Healthcare Corporation THC | 0.00 |
Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:
THC) with a Buy and raises the price target from $270 to $290.
